<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10562666</identifier>
<setSpec>0212-6982</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Quirce, R</dc:author>
<dc:author>Carril, J</dc:author>
<dc:author>Vallina, N</dc:author>
<dc:author>Montero, A</dc:author>
<dc:author>Uriarte, I</dc:author>
<dc:description xml:lang="en">A heart transplant patient treated with OKT3 developed a severe headache which worsened and was accompanied by a sudden decrease in the patient's consciousness level and aphasia when the treatment course was completed. CT was performed and was normal. SPET imaging with 99mTc-HMPAO of cerebral blood flow done 16 hours later revealed multiple and clear focal defects in the blood flow. Analysis of cerebral spinal fluid revealed aseptic pleocytosis. Five days after the completion of treatment, the symptoms remitted and a new control SPET 3 weeks later was completely normal. A diagnosis of neurotoxicity secondary to OKT3 administration was established.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>1999 Oct </dc:date>
<dc:title xml:lang="es">Efecto sobre la perfusión cerebral del tratamiento con OKT3 en paciente con trasplante cardíaco mediante SPET con HMPAO-99mTc.</dc:title>
<dc:title xml:lang="en">[Effects of treatment with OKT3 on brain perfusion in a heart transplant patient with SPET with 99mTc-HMPAO].</dc:title>
<dc:publisher>Revista espanola de medicina nuclear</dc:publisher>
</metadata>
</record>
</pubmed-document>
